Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market
Canada-based medical marijuana company Aurora Cannabis Inc.’s (NASDAQ: ACB) stock is trading lower after it released its fourth quarter 2025 earnings.
Aurora Cannabis reported a quarterly loss of 24 cents per share (equivalent to CA 35 cents) compared to the analysts’ estimate of 11 cents earnings per share.
Sales were $63.07 million (around CA 90.54 million), beating the consensus of $62.04 million.
Also Read: Germany Has Become The World’s Largest Cannabis Importer: Here Are The Stocks Benefiting
Sales increased by 34% year over year, mainly due to 48% growth in the global medical cannabis business and 32% in the plant propagation business, slightly offset by lower quarterly revenue in the consumer cannabis business.
Consolidated adjusted gross margin before fair value adjustments was 62% in the fourth quarter …